STOCK TITAN

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO) announced that it will report its third quarter fiscal year 2022 financial results on November 9, 2022, after market closure. A conference call will follow at 5:00 p.m. ET on the same day, offering a corporate update and a Q&A session. Interested participants can access the call via a live webcast or teleconference, with an archived version available on the company’s website for one year. Organogenesis focuses on regenerative medicine solutions for advanced wound care and surgical markets.

Positive
  • Upcoming financial results reporting on November 9, 2022.
  • Scheduled conference call to provide a corporate update and engage with investors.
Negative
  • None.

CANTON, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that third quarter of fiscal year 2022 financial results will be reported after the market closes on Wednesday, November 9th.

Management will host a conference call at 5:00 p.m. Eastern Time on November 9th to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.organogenesis.com. The webcast will be archived on the company website for approximately one year.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.


FAQ

When will Organogenesis report its third quarter financial results?

Organogenesis will report its third quarter financial results on November 9, 2022, after market close.

What time is the conference call for Organogenesis's third quarter results?

The conference call will be held at 5:00 p.m. Eastern Time on November 9, 2022.

How can I access the Organogenesis third quarter earnings call?

You can access the call via a live webcast or teleconference, with links provided in their press release.

Organogenesis Holdings Inc.

NASDAQ:ORGO

ORGO Rankings

ORGO Latest News

ORGO Stock Data

430.21M
74.14M
43.44%
48.28%
7.85%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANTON